Literature DB >> 17804545

Antibodies to the lens and cornea in anti-DFS70-positive subjects.

Nicola Bizzaro1, Elio Tonutti, Daniela Visentini, Maria Grazia Alessio, Stefan Platzgummer, Gabriella Morozzi, Antonio Antico, Danilo Villalta, Sonia Piller-Roner, Enrico Vigevani.   

Abstract

Autoantibodies against DFS70 (dense fine speckles 70) antigen have recently been identified among antinuclear antibodies (ANA) in patients with various inflammatory diseases and in patients with different types of cancer. These antibodies are recognized using indirect immunofluorescence (IIF) on HEp-2 cells, by a fine speckled nuclear staining in interphase HEp-2 cells and a positive reaction in the chromosome region of mitotic cells. Given that the DFS70 protein is also known as the lens epithelium-derived growth factor, this study was performed with two objectives: (a) to assess the prevalence of these antibodies in patients sent for ANA testing and in 334 patients with different types of neoplasia and (b) to determine whether the lens tissue was a suitable substrate for the detection of antibodies specific to lens proteins. During routine workup for ANA detection by the IIF method, we found 172 DFS70-positive sera among 21,516 consecutive samples (prevalence, 0.8%). In the group of patients with neoplastic disease, 6 of 334 (1.8%) were anti-DFS70-positive. DFS70-positive sera were then assayed by the IIF method on cryostatic sections of mouse eye at a dilution of 1:40 with an anti-human IgG conjugate. Among the 172 DFS70-positive samples detected by the ANA screening, 32 (19%) were strongly reactive against the reticular fibers of the lens; 8 (5%) were positive only to the corneal epithelium (nuclear negative); 5 (3%) were positive both for the cornea and the lens fibers; 13 (7%) stained only the nuclei of lens and cornea cells, and 4 (2%) were positive against the ciliary muscle. Among the patients with neoplastic diseases, only one with lung cancer reacted weakly with the reticular fibers of the lens. Sera from 20 healthy blood donors were negative. In this preliminary study, we have shown that the prevalence of anti-DFS70 antibodies is much lower than previously reported, both in patients screened for ANA and in patients with cancer. We have also seen that some DFS70-positive sera have antibodies that recognize antigens of the lens. Further studies are needed to investigate the fine specificity and the possible significance of these new autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804545     DOI: 10.1196/annals.1381.019

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

2.  Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2.

Authors:  Anamika Basu; Leanne Woods-Burnham; Greisha Ortiz; Leslimar Rios-Colon; Johnny Figueroa; Roger Albesa; Luis E Andrade; Michael Mahler; Carlos A Casiano
Journal:  Clin Immunol       Date:  2015-07-31       Impact factor: 3.969

Review 3.  [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].

Authors:  R Mierau
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 4.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

Review 5.  The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Authors:  Robert L Ochs; Michael Mahler; Anamika Basu; Leslimar Rios-Colon; Tino W Sanchez; Luis E Andrade; Marvin J Fritzler; Carlos A Casiano
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

6.  Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate.

Authors:  Kishore Malyavantham; Lakshmanan Suresh
Journal:  Auto Immun Highlights       Date:  2017-03-17

7.  Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.

Authors:  Makoto Miyara; Roger Albesa; Jean-Luc Charuel; Mohamed El Amri; Marvin J Fritzler; Pascale Ghillani-Dalbin; Zahir Amoura; Lucile Musset; Michael Mahler
Journal:  Clin Dev Immunol       Date:  2013-02-07

Review 8.  The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.

Authors:  Michael Mahler; Marvin J Fritzler
Journal:  Clin Dev Immunol       Date:  2012-12-06

9.  Confirmation of anti-DFS70 antibodies is needed in routine clinical samples with DFS staining pattern.

Authors:  Esvet Mutlu; Mete Eyigör; Derya Mutlu; Meral Gültekin
Journal:  Cent Eur J Immunol       Date:  2016-03-24       Impact factor: 2.085

Review 10.  Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.

Authors:  Chiara Spinello; Giovanni Laviola; Simone Macrì
Journal:  Front Neurosci       Date:  2016-06-30       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.